Gross Margin

After a major financial overhaul, solar firm SUNation Energy is exploring a sale, a move that could reshape its future and ripple through the hot M&A market.

ScottsMiracle-Gro divests its cannabis-focused Hawthorne unit to Vireo Growth, a strategic pivot to boost margins and exit a volatile market.

Activist investor Veradace Partners demands Repay scrap its KUBRA deal, alleging a breach of fiduciary duty and widespread shareholder opposition.

China's EdTech giant TAL is set to report Q4 earnings. Investors are watching closely to see if its pivot to AI and smart devices is a winning strategy.

The retailer posts modest annual growth despite a tough Q4, as international gains and efficiency drives offset major headwinds in its Canadian operations.

Vancouver's SalesCloser Technologies begins trading on the TSXV. Can its autonomous AI agents revolutionize the multi-billion dollar sales industry?

EDERRA's new partnership with Cepham signals a shift in wellness, blending brand transparency with manufacturing science to lead the functional food market.

The race for AI supremacy pushed semiconductor equipment sales to an unprecedented high in 2025, as Asia widens its manufacturing investment lead over the West.

With its Q1 earnings call on May 7, STARZ faces investor scrutiny on subscriber growth, content strategy, and its path to profitability post-spinoff.

Harvard Business Review's 2025 prize signals a new era for leadership, rewarding a practical framework that moves beyond AI hype to strategic implementation.

With new clinical trial data showing its AI is superior for complex AFib, Volta Medical heads to a major conference to change the standard of care.

Facing a storm of overcapacity, geopolitical risks, and a rising China, Europe's polyolefins sector is fighting for its future. Can it survive?

Outset Medical appoints Derick Elliott as commercial EVP, a strategic move to accelerate its Tablo dialysis system and capitalize on the hospital insourcing trend.

With diagnostic sales fueling a diverse therapeutic arsenal, Telix reaffirms blockbuster guidance and advances pivotal trials for prostate, brain, and kidney cancers.

The 6th-gen Toyota RAV4 ditches gas engines, betting its all-hybrid lineup and new tech can keep it on top of the hyper-competitive small SUV market.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.

MTI replaces its Road Tour with an intense, invite-only forum, uniting top regulators and experts to find the next wave of healthcare solutions.

MetLife Investment Management hires Andrea Drasites from Blackstone to head its real estate arm, a strategic move to scale after its PineBridge acquisition.

Amidst major losses and a declining core business, China's Quhuo bets its future on a high-stakes pivot to housekeeping and vehicle exports, fueled by AI.